Safety of low molecular weight heparin (LMWH) use during pregnancy.*
| Complication . | Frequency, % (95% CI) . |
|---|---|
| Data are from Greer and Nelson-Piercy.13 | |
| *For all indications and all LMWH; N = 2777 | |
| Antenatal bleeding | 0.43 (0.22–0.75) |
| Allergic skin reaction | 1.80 (1.34–2.37) |
| Osteoporotic fracture | 0.04 (<0.01–0.20) |
| Thrombcytopenia (platelets <100 x 109/L) | 0.11 (0.02–0.32) |
| Confirmed HIT | 0.00 (0.00–0.11) |
| Complication . | Frequency, % (95% CI) . |
|---|---|
| Data are from Greer and Nelson-Piercy.13 | |
| *For all indications and all LMWH; N = 2777 | |
| Antenatal bleeding | 0.43 (0.22–0.75) |
| Allergic skin reaction | 1.80 (1.34–2.37) |
| Osteoporotic fracture | 0.04 (<0.01–0.20) |
| Thrombcytopenia (platelets <100 x 109/L) | 0.11 (0.02–0.32) |
| Confirmed HIT | 0.00 (0.00–0.11) |